Skip to main content
Download PDF

The brain-in-motion study: effect of a 6-month aerobic exercise intervention on cerebrovascular regulation and cognitive function in older adults

BMC Geriatrics volume 13, Article number: 21 (2013) Cite this article

Abstract

Background

Aging and physical inactivity are associated with declines in some cognitive domains and cerebrovascular function, as well as an elevated risk of cerebrovascular disease and other morbidities. With the increase in the number of sedentary older Canadians, promoting healthy brain aging is becoming an increasingly important population health issue. Emerging research suggests that higher levels of physical fitness at any age are associated with better cognitive functioning and this may be mediated, at least in part, by improvements in cerebrovascular reserve. We are currently conducting a study to determine: if a structured 6-month aerobic exercise program is associated with improvements or maintenance of both cerebrovascular function and cognitive abilities in older individuals; and, the extent to which any changes seen persist 6 months after the completion of the structured exercise program.

Methods/design

Two hundred and fifty men and women aged 55–80 years are being enrolled into an 18-month combined quasi-experimental and prospective cohort study. Participants are eligible for enrollment into the study if they are inactive (i.e., not participating in regular physical activity), non-smokers, have a body mass index <35.0 kg/m2, are free of significant cognitive impairment (defined as a Montreal Cognitive Assessment score of 24 or more), and do not have clinically significant cardiovascular, cerebrovascular disease, or chronic obstructive pulmonary airway disease. Repeated measurements are done during three sequential six-month phases: 1) pre-intervention; 2) aerobic exercise intervention; and 3) post-intervention. These outcomes include: cardiorespiratory fitness, resting cerebral blood flow, cerebrovascular reserve, and cognitive function.

Discussion

This is the first study to our knowledge that will examine contemporaneously the effect of an exercise intervention on both cerebrovascular reserve and cognition in an older population. This study will further our understanding of whether cerebrovascular mechanisms might explain how exercise promotes healthy brain aging. In addition our study will address the potential of increasing physical activity to prevent age-associated cognitive decline.

Background

Aging is associated with declines in certain cognitive domains and lower levels of physical activity [1, 2]. The Public Health Agency of Canada [2] and World Health Organization [3] report that adults between 65 and 74 years of age are the most sedentary portion of the population. An estimated 60% of older adults lead sedentary lifestyles and do not engage in enough physical activity to achieve favorable health benefits [4]. Physical inactivity is a recognized modifiable risk factor of cerebrovascular disease and the cognitive decline seen in older adults [5, 6]. With the projected doubling of the number of older Canadians over the next 25 years [7], it is anticipated that the personal and societal burden of age-associated conditions like cerebrovascular disease and dementia (e.g., Alzheimer’s disease, AD) will increase substantially [8].

Post-maturational aging is associated with reduced abilities in a number of cognitive processes, including attention, learning and memory, and executive control [9]. These age-related changes, while detectable, are generally considered part of the aging process and usually do not interfere with the ability to live independently. Dementia, an acquired decline in multiple cognitive areas causing a significant impairment in social or occupational functioning , occurs in approximately 8% in the older population, with AD and vascular dementia (VaD) either alone or in combination the most common causes [10, 11]. As both aging and vascular disease are risk factors for both AD and VaD, age-associated declines in cerebrovascular function might contribute to the development of these disorders [11–13].

With normal aging there is an approximately 5% decrease per decade in resting cerebral blood flow (CBF) [14]. Although the brain represents 2.0 to 2.3% of an adult’s total body weight, in percentage terms it accounts for ten times more of the body’s total resting energy consumption [15, 16]. Since cerebral tissue does not produce or store sources of energy, its high metabolic need requires constant and adequate blood supply. Age-related hypoperfusion may be associated with sufficient reductions in the delivery of oxygen and nutrients and inadequate removal of metabolic by-products to produce impaired cognitive function and slowly progressive cellular injury [17]. Neurons, glial and vascular cells are linked together in neurovascular units where neuronal and glial signals control local CBF [17–19]. With aging, neurovascular coupling is disrupted, which could result in the metabolic requirements of the brain tissue not being matched by CBF [15, 18]. Decreases in CBF have been associated with a number of age-related neurodegenerative changes including a loss of neuropil (i.e., synaptically dense regions of the nervous system mainly composed of unmyelinated axons, dendrites and glial processes) [20].

There is consistent evidence that regular exercise promotes brain health and is associated with a lower risk for age-related cognitive decline and dementia [21], however the underlying mechanisms have not been well defined [22]. Neuroimaging studies of older adults indicate that higher levels of cardiovascular fitness are associated with larger volumes of specific brain regions including the hippocampus, an important region for learning and memory [23, 24]. This effect may be attributable, in part, to neurogenesis [25] possibly mediated by increases in vascularization, elevated levels of neurotrophins and growth factors, and/or improved neuronal survival in the aging brain [26].

Previous studies have focused primarily on neuronal processes that may explain why physical activity promotes healthy brain aging while cerebrovascular mechanisms that might underlie improved cognitive function are relatively poorly understood. Pharmacological manipulation of cerebral blood flow can modify performance on a variety of cognitive tasks in both animal models and humans (for review see [15, 27]). Cerebrovascular networks are thought to have a high degree of plasticity (i.e., they are changeable or modifiable) [27]. Exercise appears to stimulate the growth of new capillaries from preexisting vessels in the brain and improve resting CBF [27, 28]. We recently demonstrated that increased levels of physical fitness were associated with greater cerebrovascular reserve (i.e., the ability of cerebral arteries to dilate in response to a stimulus) and improved cognitive function [12]. These data suggest that the link between physical fitness and cognition may be mediated, at least in part, by improvements in cerebrovascular function.

We are conducting a quasi-experimental prospective cohort study with two primary aims: 1) to determine the effect of a six-month aerobic exercise intervention on physical fitness, resting CBF, cerebrovascular reserve, and cognitive function in 250 sedentary men and women between the ages of 55 and 80 years; and, 2) to determine the extent to which the changes in cerebrovascular and cognitive function persist six months following the completion of the exercise intervention. We hypothesize the improvement in cognitive function derived from regular aerobic exercise is at least partially mediated by enhanced cerebrovascular reserve. Further, we hypothesize that these beneficial changes will persist in participants who remain physically active as compared to those who revert to a sedentary lifestyle. The purpose of this manuscript is to describe the study design and research methodologies in detail.

Methods

The Brain in Motion (BIM) study is an 18-month combined quasi-experimental and prospective cohort study consisting of three six-month phases: 1) pre-intervention phase; 2) aerobic exercise intervention phase; and 3) post-intervention (Figure 1).

Figure 1
figure1

Flow chart of the phases of the BIM study.

Full size image

Participant recruitment

The target population for enrollment is sedentary men and women aged 55–80 years. Participants are being recruited through media, poster and newspaper advertisements. Potential participants must provide informed written consent prior to enrollment into the study. Participants are also invited to provide separate written consent for genetic testing (see section on Blood Sampling and Biomarker Assessments). The study protocol was approved by the University of Calgary Conjoint Health Research Ethics Board.

Inclusion/exclusion criteria

During an initial phone interview, interested participants are assessed for their eligibility based on pre-determined inclusion and exclusion criteria (Table 1). Potential participants who successfully complete an initial telephone-based evaluation are then scheduled for a 60-minute on-site assessment of eligibility (Table 1).

Table 1 Inclusion criteria – participant must fulfill all criteria to be admitted to the study
Full size table

Study design

The BIM study design and timeline is outlined in Figure 1. A second baseline measure allows an estimate of practice effects on the cognitive test performance and an estimate of the consistency of our other various measures. Additionally, this second assessment ensures feasibility of the testing in the selected study population and that participants will comply with follow-up testing prior to the exercise intervention.

Pre-intervention baseline phase test 1A (month 0)

The baseline assessment during the pre-intervention phase is conducted during four separate on-site appointments during which the following are done: 1) fasting blood work; 2) incremental treadmill test to assess maximal aerobic capacity (VO2max); 3) assessment of cerebrovascular function; and 4) assessment of cognitive function, mood and sleep (Table 2). In addition, participants are required to fill out a Dietary History Questionnaire based on their intake over the previous 12 months [30]. Details of these evaluations are given later.

Table 2 Table of testing and questionnaires at each phase
Full size table

Pre-intervention baseline phase test 1B (month 6)

Six months following enrollment into the study, and immediately prior to the exercise intervention phase, participants undergo the same evaluations as done during Pre-Intervention Baseline Phase Test 1A (see Table 2 for details). At an additional visit, the Lifetime Physical Activity Questionnaire[31] is administered by study personnel.

Exercise intervention phase (months 6–12)

Participants then take part in the supervised six-month aerobic training program that is held three days per week at the Fitness Centre in the Faculty of Kinesiology at the University of Calgary. Each exercise session includes a five-minute warm up, aerobic exercise, a five-minute cool down, and stretching. Exercise prescriptions follow American College of Sports Medicine guidelines [32]. As participants progress through the exercise intervention, the duration of aerobic exercise (in addition to warm up and cool down) increases from 20 to 40 minutes. Exercise intensity is determined based on individual VO2max. The intensity builds from 30–45% until 60–70% maximum heart rate reserve (HRR) is achieved. Participants wear a Polar® heart rate monitor at each session to ensure compliance to their target heart rate zones. Heart rate data are collected and stored during each exercise session and are then exported offline following the exercise session to analyze heart rates during the exercise session (Polar® Team2 system). Participants are considered compliant if they attend at least 85% of the total exercise sessions. If an exercise session is missed, participants are strongly encouraged to “make-up” the session independently and record the unsupervised exercise session in a personal workout logbook. In addition to “make-up” exercise sessions, participants are also required to record any additional independent unsupervised exercise sessions.

Intervention phase test 2A (month 9)

Midway (3 months) through the exercise program, participants undergo repeat testing (same evaluations done during Phase Test 1A/1B (see Table 2 for details)) to assess for changes in parameters over time. Based on their results, exercise prescriptions for participants may be adjusted. In addition, sleep and mood are assessed by self-report questionnaires.

Exercise intervention phase test 2B (month 12)

Repeat testing is again done at the end of the 6-month intervention (see Table 2 for details). The Dietary History Questionnaire[28] and a Past Year Physical Activity Questionnaire[33] (details given later) are self-administered questionnaires completed at this time point.

Post-intervention phase test 3 (month 18)

Six-months following the completion of the exercise intervention, participants are re-evaluated (see Table 2 for details). During this six-month period, participants independently decide whether or not they continue with an exercise program. A Past Six-Month Physical Activity Questionnaire[33] is completed by participants to determine the amount of physical activity they engaged in following the completion of the supervised exercise sessions. This questionnaire permits a categorization of participants by their activity levels to help assess the extent to which changes in cerebrovascular and cognitive function are maintained six-months following the exercise intervention.

Blood sampling and biomarker assessments

Fasted venous blood samples are collected five times from each participant as shown in Figure 1. Sex steroid hormone status (estradiol, progesterone, testosterone, sex hormone binding globulin), lipids (cholesterol, high and low density lipoprotein, triglycerides), hematology (complete blood count), thyroid (thyroid stimulating hormone), renal (creatinine), hepatic (alanine aminotransferase and bilirubin), and markers of vascular function influenced by age and physical fitness [34] (i.e., oxidative and nitrative stress, antioxidant enzyme capacity, and products of nitric oxide metabolism) are being measured.

For participants who provide consent for genetic testing, blood samples are also collected for this purpose. This testing will include catechol-O-methyl-transferase, brain-derived neurotropic factor, and apolipoprotein E ε4 genotyping, which have previously been shown to influence cognitive performance [35–37]. In addition, vascular endothelial growth factor genotyping, which can be influenced by exercise presumably via vascular-mediated mechanisms, will also be done [38].

Maximal aerobic capacity and anthropometric measurements

All participants undergo assessments of fitness level by a maximal aerobic capacity (VO2max) test and anthropometric measurements during each phase. Participants are instructed to refrain from vigorous exercise the day of testing, ingesting caffeine and/or alcohol six hours prior to testing and eating a heavy meal four hours prior to testing. Anthropometric measurements include height, weight, circumference measurements (waist and hip), body composition (bioelectrical impedance analysis), and grip strength. The VO2max test is conducted on a motorized treadmill and follows the Bruce protocol [39]. A plateau in oxygen uptake with increasing work rate is observed (<2 mL/kg/min), a respiratory exchange ratio (RER) of at least 1.15, and age-predicted maximal heart rate (210-(age X 0.65)) are used as criteria for stopping the test (as recommended by the Canadian Society for Exercise Physiology (CSEP) [40] and American Thoracic Society (ATS) [41]). Outcome measures for the VO2max test include oxygen uptake, carbon dioxide production, ventilation (tidal volume and breathing frequency), rating of perceived exertion (Borg scale), continuous heart rate recordings (12-lead electrocardiogram (ECG)), and systemic blood pressure.

This fitness test determines each study participant’s maximal aerobic capacity that is used to determine work rates for the submaximal exercise test (during the cerebrovascular function test) and the target heart rate zones for the exercise intervention.

Cerebrovascular function

Cerebrovascular response to carbon dioxide and submaximal exercise is assessed in participants who have refrained from exercising the day of the test and eating or drinking anything other than water, two hours prior to testing. A capillary blood sample is taken from the middle finger and immediately analyzed for PO2 and PCO2, acid/base status, glucose, hematocrit, potassium, sodium, chloride, and calcium levels (Radiometer ABL 800, Denmark). Participants sit quietly in a chair while they are fitted with monitoring equipment. In order to noninvasively measure the CBF of the middle cerebral artery (MCA), a 2-MHz transcranial Doppler ultrasound (TCD) is used (Toc Neurovision™, Multigon Industries, Inc., Yonkers, NY) [42]. To locate the MCA, the TCD probe is placed in the temporal region just above the end of the zygomatic process close to the ear, using techniques previously described [42]. Maximum peak velocity ( V ¯ P ), intensity-weighted mean ( V ¯ IWM ), an index of the cross-sectional area of the vessel called power ( P ¯ ), cerebrovascular conductance, and cerebrovascular reserve are recorded as previously described [12]. Outcome measures for this test include continuous TCD recordings, heart rate (3-lead ECG; Micromon 7142 B, Kontron Medical, Milton Keynes, UK), blood pressure (beat-by-beat using finger pulse photoplethysmography, Finometer, Finapres Medical Systems, Amsterdam, The Netherlands), and arterial hemoglobin saturation (finger pulse oximetry; 3900p, Datex-Ohmeda, Madison, WI, USA).

We have previously developed and tested the protocol for this test [12]. In short, baseline end-tidal respiratory measures (PCO2 and PO2) are recorded using dedicated software (Chamber, University Laboratory of Physiology, Oxford, UK), during a 10-minute baseline period. With their nose occluded, each participant breathes through a mouthpiece connected to a fine capillary that is connected to a mass spectrometer (AMIS 2000, Innovision, Odense, Denmark) in which end-tidal respiratory measures (PCO2 and PO2) are analyzed. These end-tidal gases are averaged over the 10 minutes, and are used to determine the desired end-tidal pressure carbon dioxide (PETCO2) and end-tidal pressure oxygen (PETO2) for cerebrovascular response to an euoxic hypercapnia test. Control of desired PETCO2 and PETO2 values is achieved accurately and continuously using sophisticated software (BreatheM v2.40, University Laboratory of Physiology, Oxford, UK) and dynamic end-tidal forcing technique as previously described [43, 44]. The test lasts 17 minutes with two 3-minute steps of carbon dioxide. For the first minute, participants breathe room air only. This time period is followed by a five-minute baseline period in which the PETCO2 is held at +1.0 mmHg above the participants’ resting PETCO2 value. Following baseline, PETCO2 is increased to +5.0 mmHg above normal resting values and held for three minutes and then is increased to +8.0 mmHg and is again held for three minutes. Lastly, PETCO2 is dropped back down to +1.0 mmHg above resting values and held for the final five minutes of the test.

Following the hypercapnia test, participants rest for 20–30 minutes. Then, participants are seated on the recumbent cycle ergometer and cerebrovascular response to submaximal exercise is assessed. This test lasts 30 minutes during which participants complete two six-minute intervals of exercise as previously described [12].

Assessment of cognition, mood, sleep, and social support

Participants undergo cognitive testing four times, at six month intervals, during the course of the study (see Table 3 for details of the specific standardized and experimental tests done). The tests were chosen to assess cognitive domains that had previously been shown to be affected by fitness training, with a special focus on executive functions, processing speed, and memory [21, 27, 45]. In addition, we will look for changes in mood [46] and sleep [47, 48] using validated self-report questionnaires. Involvement in the study might modify the perception by participants of their observed social support (i.e., the feeling that one is care for, has assistance available from other people, and that one is part of a supportive social network). As higher levels of perceived social support could increase adherence to the exercise program and have an independent beneficial impact on both mental and physical health (see [49] for review and discussion), perceived social support will be measured during the course of the study by a modified version of the Lubben Social Network Scale [50]. The testing sessions lasts approximately 120 minutes with short breaks taken as necessary. The same testing order is maintained through all assessments during the study.

Table 3 BIM neuropsychological assessment
Full size table

Questionnaires

Physical activity questionnaires

At Pre-intervention Phase Test 1B participants complete the interviewer-administered Lifetime Physical Activity Questionnaire to quantify lifetime occupational, household, and exercise/sports activities and used to determine lifetime physical activity patterns [31]. The Past Year Physical Activity Questionnaire[33] is self-reported and given to participants immediately following the completion of the exercise intervention, which assesses physical activities while enrolled in the BIM study. At the completion of the study (Post-intervention Phase 3), participants are given the Past Six Month Physical Activity Questionnaire to assess their activity level six-months following completion of the exercise intervention.

Diet history questionnaire

The Diet History Questionnaire (DHQ) is a self-administered food frequency questionnaire originally designed by the National Cancer Institute but modified for use in Canada [30]. Consisting of 146 questions about 124 different food items, the questionnaire includes questions about portion size, seasonal intake, and fat usage within the past 12 months [30]. Participants complete the questionnaire at enrollment into the study and following the completion of the exercise intervention.

Statistical analysis

The primary outcome measure is the change in overall cognitive function (defined as the average of standardized cognitive domain scores) over time. The sample size estimates assume a two-tailed alpha level of 0.05, power of 90% (β = 0.1) and a change in overall cognitive score of 0.2 standard deviation units based on Brown et al. [12]. To account for a predicted 15% dropout rate to account for withdrawals [63] and non-compliance with the exercise sessions (i.e., attendance 85% or less of all sessions), we will recruit 125 men and 125 women (n = 250). The primary outcome analysis within individuals will use repeated measures analysis of variance using a general linear mixed model. Cardiorespiratory fitness, vascular measurements of resting CBF, cerebrovascular reserve, cerebrovascular conductance, mood and sleep are secondary outcome measures. The covariates being considered in our analysis include age, sex, education, socio-economic status, BMI, hormones, lipids profiles, genetics, diet, physical activity and physical fitness (i.e. VO2max). Multivariable methods will be used to determine if covariates are predictors of our primary outcome measure (overall cognition) [12].

Discussion

Current projections suggest that by 2031, approximately 25% of the Canadian population will be over the age of 65 [7] and in 2050, the estimated world population over the age of 60 will be 2 billion [3]. With societal aging, a progressive increase in the absolute number of individuals suffering from age-associated health issues like cerebrovascular disease, VaD, and AD will inevitably occur unless we can change the likelihood of these events occurring. If we cannot, population aging will lead to a significantly greater burden on the health and social care system of our country and around the world. Effective prevention of these diseases is of paramount importance. A promising approach is encouraging higher levels of physical activity since exercise may delay or prevent the progression of cognitive decline associated with aging, prevent cerebrovascular disease, and delay the onset of AD and related dementias [64].

The BIM study is designed to add to the literature on whether exercise can be an effective means of decreasing the effects of aging on cognition. This study will combine detailed physiological and cognitive data with sociodemographic, biologic, and lifestyle information obtained from a relatively large and well defined older population. By performing an exercise intervention we are able to investigate the extent to which cerebrovascular physiology might act as a mediating factor between exercise and cognition. If confirmed this raises the possibility of cerebrovascular measures functioning as a surrogate marker of brain health in future studies of exercise interventions.

The BIM study uses state-of-the-art measurements of cerebrovascular function, physical fitness, cognitive function, lifestyle, sleep, biologic, and genetic markers all of which strengthen the study. The Laboratory for Human Cerebrovascular Physiology houses sophisticated equipment to control end-tidal PO2 and PCO2 accurately and continuously using our dynamic forcing-function system. The VO2max testing protocols used in the study are considered the “gold-standard” practice for the assessment of physical fitness, thereby adding strength to the study since we avoid problems associated with predictive tests by measuring VO2max rather than VO2peak [65]. The comprehensive neuropsychological test battery allows us to assess multiple aspects of cognitive function. The battery is administered at multiple time points through the study that will allow the assessment of whether the exercise intervention has an impact on cognitive function, how long it takes to become evident, and its duration. We have included numerous self-administered questionnaires to measure changes in dietary intake, sleep habits, physical activity levels and cognitive abilities at differing time points. Collectively, these data will provide insights regarding the possible mechanisms whereby exercise improves cerebrovascular and cognitive function.

The current study is unique because all the participants of our study attend our supervised and structured exercise program for six-months. Further, the exercise program is individually tailored to each participant as exercise prescriptions are based on each individual’s heart rate reserve. This supervised intervention assesses participants’ progression through the exercise program with modifications to the intervention made as needed. The BIM study uses a quasi-experimental prospective cohort design because it reduces variability over time since each participant is their own control during the repeated baseline assessment over a six-month period. An inherent weakness is the potential carry over or practice effects in repeated cognitive testing. We have attempted to deal with this issue by 1) repeating the baseline cognitive testing to observe the stability of the performance measures over time before the intervention, 2) using alternate forms of tests when possible (i.e., verbal fluency, selective reminding, MCG figure, card sorting), and 3) we will analyze the cognitive data for overall trends at the four time points to examine for a global practice effect over time. The next logical step in our research program will be a randomized controlled trial in first a healthy and then in a diseased population (e.g. individuals with Mild Cognitive Impairment or stroke).

The mechanisms whereby exercise-induced increases in cerebrovascular reserve improve cognitive function are unknown. At this time, we are focused on demonstrating the physiologic mechanisms by which exercise confers its beneficial influence on cognition. The BIM study is the first to examine the influence of an aerobic exercise intervention on cerebrovascular and cognitive function in a healthy aging population. The results from this study may inform the development of new therapies to reduce or prevent the cognitive decline associated with aging.

Abbreviations

AD:

Alzheimer’s disease

CBF:

Cerebral blood flow

BIM:

Brain in motion

BMI:

Body mass index

MoCA:

Montreal cognitive assessment

VO2max:

Maximal aerobic capacity

HRR:

Heart rate reserve

RER:

Respiratory exchange ratio

ECG:

Electrocardiogram

MCA:

Middle cerebral artery

PO2:

Endtidal oxygen

PCO2:

Endtidal carbon dioxide

TCD:

Transcranial doppler ultrasound

VaD:

Vascular dementia

V ¯ P :

Peak velocity

V ¯ IWM :

Intensity-weighted mean

P ¯ :

Power

PETCO2 :

End-tidal pressure carbon dioxide

PETO2 :

End-tidal pressure oxygen

D-KEFS:

Delis-kaplan executive function system

MCG:

Medical college of georgia complex figure

DHQ:

Diet history questionnaire.

References

  1. 1.

    Middleton LE, Barnes DE, Lui L, Yaffe K: Physical activity over the life course and its association with cognitive performance and impairment in old age. J Am Geriatr Soc. 2010, 58 (7): 1322-1326. 10.1111/j.1532-5415.2010.02903.x.

    Article  PubMed  PubMed Central  Google Scholar 

  2. 2.

    Public Health Agency of Canada- Physical Activity and Older Adults. http://publications.gc.ca/collections/Collection/H88-4-1999E.pdf,

  3. 3.

    Dementia: A Public Health Priority. http://whqlibdoc.who.int/publications/2012/9789241564458_eng.pdf,

  4. 4.

    Canada’s Physical Activity Guide to Healthy Active Living for Older Adults. http://www.alcoa.ca/e/projects/canguide.htm,

  5. 5.

    Gorelick PB, Sacco RL, Smith DB, Alberts M, Mustone-Alexander L, Rader D, Ross JL, Raps E, Ozer MN, Brass LM, Malone ME, Goldberg S, Booss J, Hanley DF, Toole JF, Greengold NL, Rhew DC: Prevention of a first stroke: a review of guidelines and a multidisciplinary consensus statement from the national stroke association. J Am Med Assoc. 1999, 281 (12): 1112-1120. 10.1001/jama.281.12.1112.

    CAS  Article  Google Scholar 

  6. 6.

    Laurin D, Verreault R, Lindsay J, MacPherson K, Rockwood K: Physical activity and risk of cognitive impairment and dementia in elderly persons. Arch Neurol. 2001, 58 (3): 498-504. 10.1001/archneur.58.3.498.

    CAS  Article  PubMed  Google Scholar 

  7. 7.

    Statistics Canada 2010- Population projections: Canada, the provinces and territories (2009–2036). http://www.statcan.gc.ca/pub/91-520-x/91-520-x2010001-eng.pdf,

  8. 8.

    Bishop NA, Lu T, Yankner BA: Neural mechanisms of ageing and cognitive decline. Nature. 2010, 464 (7288): 529-535. 10.1038/nature08983.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  9. 9.

    Grady C: The cognitive neuroscience of ageing. Nat Rev Neurosci. 2012, 13 (7): 491-505. 10.1038/nrn3256.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  10. 10.

    Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH: The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the national institute on aging-Alzheimer’s association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011, 7 (3): 270-279. 10.1016/j.jalz.2011.03.008.

    Article  PubMed  PubMed Central  Google Scholar 

  11. 11.

    Silvestrini M, Pasqualetti P, Baruffaldi R, Bartolini M, Handouk Y, Matteis M, Moffa F, Provinciali L, Vernieri F: Cerebrovascular reactivity and cognitive decline in patients with Alzheimer disease. Stroke. 2006, 37 (4): 1010-1015. 10.1161/01.STR.0000206439.62025.97.

    Article  PubMed  Google Scholar 

  12. 12.

    Brown AD, McMorris CA, Longman RS, Leigh R, Hill MD, Friedenreich CM, Poulin MJ: Effects of cardiorespiratory fitness and cerebral blood flow on cognitive outcomes in older women. Neurobiol Aging. 2010, 31 (12): 2047-2057. 10.1016/j.neurobiolaging.2008.11.002.

    Article  PubMed  Google Scholar 

  13. 13.

    Riecker A, Grodd W, Klose U, Schulz JB, Gröschel K, Erb M, Ackermann H, Kastrup A: Relation between regional functional MRI activation and vascular reactivity to carbon dioxide during normal aging. J Cereb Blood Flow Metab. 2003, 23 (5): 565-573.

    Article  PubMed  Google Scholar 

  14. 14.

    Grolimund P, Seiler RW: Age dependence of the flow velocity in the basal cerebral arteries - a transcranial Doppler ultrasound study. Ultrasound Med Biol. 1988, 14 (3): 191-198. 10.1016/0301-5629(88)90139-1.

    CAS  Article  PubMed  Google Scholar 

  15. 15.

    Davenport MH, Hogan DB, Eskes GA, Longman RS, Poulin MJ: Cerebrovascular reserve: the link between fitness and cognitive function?. Exerc Sport Sci Rev. 2012, 40 (3): 153-158.

    PubMed  Google Scholar 

  16. 16.

    Cunnane S, Nugent S, Roy M, Courchesne-Loyer A, Croteau E, Tremblay S, Castellano A, Pifferi F, Bocti C, Paquet N, Begdouri H, Bentourkia M, Turcotte E, Allard M, Barberger-Gateau P, Fulop T, Rapoport SI: Brain fuel metabolism, aging, and Alzheimer’s disease. Nutrition. 2011, 27 (1): 3-20. 10.1016/j.nut.2010.07.021.

    CAS  Article  PubMed  Google Scholar 

  17. 17.

    Iadecola C: Neurovascular regulation in the normal brain and in Alzheimer’s disease. Nat Rev Neurosci. 2004, 5 (5): 347-360. 10.1038/nrn1387.

    CAS  Article  PubMed  Google Scholar 

  18. 18.

    Girouard H, Iadecola C: Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease. J Appl Physiol. 2006, 100 (1): 328-335. 10.1152/japplphysiol.00966.2005.

    CAS  Article  PubMed  Google Scholar 

  19. 19.

    Attwell D, Iadecola C: The neural basis of functional brain imaging signals. Trends Neurosci. 2002, 25 (12): 621-625. 10.1016/S0166-2236(02)02264-6.

    CAS  Article  PubMed  Google Scholar 

  20. 20.

    Ahlskog JE, Geda YE, Graff-Radford NR, Petersen RC: Physical exercise as a preventive or disease-modifying treatment of dementia and brain aging. Mayo Clin Proc. 2011, 86 (9): 876-884. 10.4065/mcp.2011.0252.

    Article  PubMed  PubMed Central  Google Scholar 

  21. 21.

    Eskes GA, Longman S, Brown AD, McMorris CA, Langdon KD, Hogan DB, Poulin M: Contribution of physical fitness, cerebrovascular reserve and cognitive stimulation to cognitive function in postmenopausal women. Front Aging Neurosci. 2010, 2: 1-7.

    Article  Google Scholar 

  22. 22.

    Voss MW, Nagamatsu LS, Liu-Ambrose T, Kramer AF: Exercise, brain, and cognition across the life span. J Appl Physiol. 2011, 111 (5): 1505-1513. 10.1152/japplphysiol.00210.2011.

    Article  PubMed  PubMed Central  Google Scholar 

  23. 23.

    Erickson KI, Voss MW, Prakash RS, Basak C, Szabo A, Chaddock L, Kim JS, Heo S, Alves H, White SM, Wojcicki TR, Mailey E, Vieira VJ, Martin SA, Pence BD, Woods JA, McAuley E, Kramer AF: Exercise training increases size of hippocampus and improves memory. Proc Natl Acad Sci U S A. 2011, 108 (7): 3017-3022. 10.1073/pnas.1015950108.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  24. 24.

    Colcombe SJ, Erickson KI, Scalf PE, Kim JS, Prakash R, McAuley E, Elavsky S, Marquez DX, Hu L, Kramer AF: Aerobic exercise training increases brain volume in aging humans. J Gerontol A Biol Sci Med Sci. 2006, 61 (11): 1166-1170. 10.1093/gerona/61.11.1166.

    Article  PubMed  Google Scholar 

  25. 25.

    Burns JM, Cronk BB, Anderson HS, Donnelly JE, Thomas GP, Harsha A, Brooks WM, Swerdlow RH: Cardiorespiratory fitness and brain atrophy in early Alzheimer disease. Neurology. 2008, 71 (3): 210-216. 10.1212/01.wnl.0000317094.86209.cb.

    Article  PubMed  PubMed Central  Google Scholar 

  26. 26.

    Middleton LE, Yaffe K: Promising strategies for the prevention of dementia. Arch Neurol. 2009, 66 (10): 1210-1215. 10.1001/archneurol.2009.201.

    Article  PubMed  PubMed Central  Google Scholar 

  27. 27.

    Churchill JD, Galvez R, Colcombe S, Swain RA, Kramer AF, Greenough WT: Exercise, experience and the aging brain. Neurobiol Aging. 2002, 23 (5): 941-955. 10.1016/S0197-4580(02)00028-3.

    Article  PubMed  Google Scholar 

  28. 28.

    Ainslie PN, Cotter JD, George KP, Lucas S, Murrell C, Shave R, Thomas KN, Williams MJA, Atkinson G: Elevation in cerebral blood flow velocity with aerobic fitness throughout healthy human ageing. J Physiol (Lond ). 2008, 586 (16): 4005-4010. 10.1113/jphysiol.2008.158279.

    CAS  Article  Google Scholar 

  29. 29.

    Rossetti HC, Lacritz LH, Munro Cullum C, Weiner MF: Normative data for the Montreal cognitive assessment (MoCA) in a population-based sample. Neurology. 2011, 77 (13): 1272-1275. 10.1212/WNL.0b013e318230208a.

    Article  PubMed  Google Scholar 

  30. 30.

    Csizmadi I, Kahle L, Ullman R, Dawe U, Zimmerman TP, Friedenreich CM, Bryant H, Subar AF: Adaptation and evaluation of the national cancer Institute’s diet history questionnaire and nutrient database for Canadian populations. Public Health Nutr. 2007, 10 (1): 88-96.

    Article  PubMed  Google Scholar 

  31. 31.

    Friedenreich CM, Courneya KS, Bryant HE: The lifetime total physical activity questionnaire: development and reliability. Med Sci Sports Exerc. 1998, 30 (2): 266-274. 10.1097/00005768-199802000-00015.

    CAS  Article  PubMed  Google Scholar 

  32. 32.

    Thompson WR, Gordon NF, Pescatello LS, American College of Sports Medicine: ASCM’s guidelines for exercise testing and prescription. 2010, Philadelphia: Lippincott Williams & Wilkins, 8

    Google Scholar 

  33. 33.

    Friedenreich CM, Courneya KS, Neilson HK, Matthews CE, Willis G, Irwin M, Troiano R, Ballard-Barbash R: Reliability and validity of the past year total physical activity questionnaire. Am J Epidemiol. 2006, 163 (10): 959-970. 10.1093/aje/kwj112.

    Article  PubMed  Google Scholar 

  34. 34.

    Pialoux V, Brown AD, Leigh R, Friedenreich CM, Poulin MJ: Effect of cardiorespiratory fitness on vascular regulation and oxidative stress in postmenopausal women. Hypertension. 2009, 54 (5): 1014-1020. 10.1161/HYPERTENSIONAHA.109.138917.

    CAS  Article  PubMed  Google Scholar 

  35. 35.

    Barnett JH, Jones PB, Muller U, Robbins TW: Effects of the catechol-O-methyltransferase Val.sup.158]Met polymorphism on executive function: a meta-analysis of the Wisconsin Card Sort Test in schizophrenia and healthy controls. Mol Psychiatry. 2007, 12: 502+-

    CAS  PubMed  Google Scholar 

  36. 36.

    Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD: Apolipoprotein E: High-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A. 1993, 90 (5): 1977-1981. 10.1073/pnas.90.5.1977.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  37. 37.

    Vaynman S, Ying Z, Gomez-Pinilla F: Hippocampal BDNF mediates the efficacy of exercise on synaptic plasticity and cognition. Eur J Neurosci. 2004, 20 (10): 2580-2590. 10.1111/j.1460-9568.2004.03720.x.

    Article  PubMed  Google Scholar 

  38. 38.

    Latimer CS, Searcy JL, Bridges MT, Brewer LD, Popović J, Blalock EM, Landfield PW, Thibault O, Porter NM: Reversal of glial and neurovascular markers of unhealthy brain aging by exercise in middle-aged female mice. PLoS One. 2011, 6 (10): e26812-10.1371/journal.pone.0026812.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  39. 39.

    Paterson DH, Cunningham DA, Koval JJ, St. Croix CM: Aerobic fitness in a population of independently living men and women aged 55–86 years. Med Sci Sports Exerc. 1999, 31 (12): 1813-1820. 10.1097/00005768-199912000-00018.

    CAS  Article  PubMed  Google Scholar 

  40. 40.

    Canadian Society for Exercise Physiology: Professional Fitness and Lifestyle Consultant: Resource Manual, Canadian Society for Exercise Physiology. 1996, Ottawa: Canadian Society for Exercise Physiology

    Google Scholar 

  41. 41.

    Anonymous : ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2003, 167 (2): 211-277.

    Article  Google Scholar 

  42. 42.

    Aaslid R, Markwalder TM, Nornes H: Noninvasive transcranial Doppler ultrasound recording of flow velocity in basal cerebral arteries. J Neurosurg. 1982, 57 (6): 769-774. 10.3171/jns.1982.57.6.0769.

    CAS  Article  PubMed  Google Scholar 

  43. 43.

    Poulin MJ, Liang P, Robbins PA: Dynamics of the cerebral blood flow response to step changes in end- tidal PCO2 and PO2 in humans. J Appl Physiol. 1996, 81 (3): 1084-1095.

    CAS  PubMed  Google Scholar 

  44. 44.

    Lambertsen CJ: Invited Editorial on ‘Fast and slow components of cerebral blood flow response to step decreases in end-tidal PCO2 in humans’. J Appl Physiol. 1998, 85 (2): 386-387.

    CAS  PubMed  Google Scholar 

  45. 45.

    Colcombe S, Kramer AF: Fitness effects on the cognitive function of older adults: a meta-analytic study. Psychol Sci. 2003, 14 (2): 125-130. 10.1111/1467-9280.t01-1-01430.

    Article  PubMed  Google Scholar 

  46. 46.

    McNair D, Lorr M, Droppleman L: Profile of Mood States. 1981, San Diego, CA: Educational and Industrial Testing Service

    Google Scholar 

  47. 47.

    Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ: The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989, 28 (2): 193-213. 10.1016/0165-1781(89)90047-4.

    CAS  Article  PubMed  Google Scholar 

  48. 48.

    Johns MW: A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991, 14 (6): 540-545.

    CAS  PubMed  Google Scholar 

  49. 49.

    Kremen WS, Lachman ME, Pruessner JC, Sliwinski M, Wilson RS: Mechanisms of age-related cognitive change and targets for intervention: social interactions and stress. J Gerontol A Biol Sci Med Sci. 2012, 67 A (7): 760-765.

    Article  Google Scholar 

  50. 50.

    Lubben J, Blozik E, Gillmann G, Iliffe S, Von Kruse WR, Beck JC, Stuck AE: Performance of an abbreviated version of the lubben social network scale among three European community-dwelling older adult populations. Gerontologist. 2006, 46 (4): 503-513. 10.1093/geront/46.4.503.

    Article  PubMed  Google Scholar 

  51. 51.

    Fan J, McCandliss BD, Sommer T, Raz A, Posner MI: Testing the efficiency and independence of attentional networks. J Cogn Neurosci. 2002, 14 (3): 340-347. 10.1162/089892902317361886.

    Article  PubMed  Google Scholar 

  52. 52.

    Callejas A, Lupiàñez J, Funes MJ, Tudela P: Modulations among the alerting, orienting and executive control networks. Exp Brain Res. 2005, 167 (1): 27-37. 10.1007/s00221-005-2365-z.

    Article  PubMed  Google Scholar 

  53. 53.

    Posner MI, Petersen SE: The attentional system of the human brain. Annu Rev Neurosci. 1990, 13: 25-42. 10.1146/annurev.ne.13.030190.000325.

    CAS  Article  PubMed  Google Scholar 

  54. 54.

    Stuss DT, Stethem LL, Poirier CA: Comparison of three tests of attention and rapid information processing across six age groups. Clin Neuropsychol. 1987, 1 (2): 139-152. 10.1080/13854048708520046.

    Article  Google Scholar 

  55. 55.

    Lezak M: Neuropsychological Assessment. 2004, New York: Oxford University Press

    Google Scholar 

  56. 56.

    Buschke H, Altman Fuld P: Evaluating storage, retention and retrieval in disordered memory and learning. Neurology. 1974, 24 (11): 1019-1025. 10.1212/WNL.24.11.1019.

    CAS  Article  PubMed  Google Scholar 

  57. 57.

    Hannay HJ, Levin HS: Selective reminding test: an examination of the equivalence of four forms. J Clin Exp Neuropsychol. 1985, 7 (3): 251-263. 10.1080/01688638508401258.

    CAS  Article  PubMed  Google Scholar 

  58. 58.

    Meador KJ, Moore EE, Nichols ME, Abney OL, Taylor HS, Zamrini EY, Loring DW: The role of cholinergic systems in visuospatial processing and memory. J Clin Exp Neuropsychol. 1993, 15 (5): 832-842. 10.1080/01688639308402599.

    CAS  Article  PubMed  Google Scholar 

  59. 59.

    Delis DC, Kaplan E, Kramer JH: Delis Kaplan Executive Functioning System (D-KEFS). 2001, San Antonio: NCS Pearson, Inc

    Google Scholar 

  60. 60.

    Uttl B: North American adult reading test: Age norms, reliability, and validity. J Clin Exp Neuropsychol. 2002, 24 (8): 1123-1137. 10.1076/jcen.24.8.1123.8375.

    Article  PubMed  Google Scholar 

  61. 61.

    Nyenhuis DL, Yamamoto C, Lucheta T, Terrien A, Parmentier A: Adult and geriatric normative data and validation of the profile of mood states. J Clin Psychol. 1999, 55 (1): 79-86. 10.1002/(SICI)1097-4679(199901)55:1<79::AID-JCLP8>3.0.CO;2-7.

    CAS  Article  PubMed  Google Scholar 

  62. 62.

    Wilson RS, Bennett DA, Beckett LA, Morris MC, Gilley DW, Bienias JL, Scherr PA, Evans DA: Cognitive activity in older persons from a geographically defined population. J Gerontol B Psychol Sci Soc Sci. 1999, 54 (3): P155-P160.

    CAS  Article  PubMed  Google Scholar 

  63. 63.

    Deley G, Kervio G, Van Hoecke J, Verges B, Grassi B, Casillas J: Effects of a one-year exercise training program in adults over 70 years old: a study with a control group. Aging Clin Exp Res. 2007, 19 (4): 310-315.

    Article  PubMed  Google Scholar 

  64. 64.

    Lautenschlager NT, Cox KL, Flicker L, Foster JK, Van Bockxmeer FM, Xiao J, Greenop KR, Almeida OP: Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: a randomized trial. JAMA. 2008, 300 (9): 1027-1037. 10.1001/jama.300.9.1027.

    CAS  Article  PubMed  Google Scholar 

  65. 65.

    Rodahl K, Per-Olof êAstrand: Textbook of Work Physiology: Physiological Bases of Exercise.Volume 4. From evaluation of physical performance on the basis of tests. 2003, McGraw-Hill, 273-299.

    Google Scholar 

Pre-publication history

  1. The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2318/13/21/prepub

Download references

Acknowledgements

The present study is supported by the Canadian Institutes of Health Research operating grant (735144; MJP (Principal Applicant), GAE, CMF, MDH, DBH, RSL (Co-Applicants), TJA, RL and EES (Collaborators)), Alzheimer Society Research Program doctoral award (AVT), Heart and Stroke Foundation of Canada- Focus on Stroke Postdoctoral fellowship (MHD), Alberta Innovates-Health Solutions (MJP, MDH (Senior Scholar), CMF (Health Senior Scholar), GAE (Visiting Scientist), GAL (Postgraduate Fellowship)), Heart & Stroke Foundation Visiting Scientist (GAE), The Brenda Stafford Foundation Chair in Geriatric Medicine of the University of Calgary (DBH), The Brenda Strafford Foundation (DBH, MJP), Heart & Stroke Foundation of Alberta, NWT and Nunavut (MDH), and the Alberta Cancer Foundation Weekend to End Breast Cancer Chair (CMF). We thank Polar® for their support and contribution of the heart rate monitoring equipment and the Team2 system used during the exercise intervention sessions. We also thank the Dean (Dr. Wayne Giles (2006–2012)) and the Faculty of Kinesiology for the support in facilitating the exercise intervention. We thank Brad Hansen (technical support), Kristin Sabourin (physiological and exercise testing), and Jacqueline Harrison (physiological testing and data analysis) in Dr. Marc Poulin’s Laboratory of Human Cerebrovascular Physiology for their assistance in testing. We also thank Dr. Stephen Wilton and Dr. Billie-Jean Martin for providing medical coverage for exercise testing.

Author information

Affiliations

  1. Department of Physiology & Pharmacology, Faculty of Medicine, University of Calgary, Calgary, Alberta, T2N 4N1, Canada

    Amanda V Tyndall, Margie H Davenport, Grazyna M Burek, Genevieve Arsenault-Lapierre, Eryka Haley, Gail A Eskes, Richard Leigh & Marc J Poulin

  2. Hotchkiss Brain Institute, Faculty of Medicine, University of Calgary, Calgary, Alberta, T2N 4N1, Canada

    Amanda V Tyndall, Margie H Davenport, Grazyna M Burek, Genevieve Arsenault-Lapierre, Eryka Haley, Michael D Hill, David B Hogan, R Stewart Longman, Eric E Smith & Marc J Poulin

  3. Department of Medicine, Faculty of Medicine, University of Calgary, Calgary, Alberta, T2N 4N1, Canada

    Ben J Wilson, Michael D Hill, David B Hogan & Richard Leigh

  4. Department of Clinical Neurosciences, Faculty of Medicine, University of Calgary, Calgary, Alberta, T2N 4N1, Canada

    Genevieve Arsenault-Lapierre, Michael D Hill, David B Hogan, Eric E Smith & Marc J Poulin

  5. Department of Psychiatry, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, B3H 2E2, Canada

    Gail A Eskes

  6. Department of Psychology, Faculty of Science, Dalhousie University, Halifax, Nova Scotia, B3H 4R2, Canada

    Gail A Eskes

  7. Department of Medicine (Neurology), Dalhousie University, Halifax, Nova Scotia, B3H 3A7, Canada

    Gail A Eskes

  8. Department of Population Health Research, Alberta Health Services-Cancer Care, Calgary, Alberta, T2S 3C3, Canada

    Christine M Friedenreich

  9. Department of Oncology, Faculty of Medicine, University of Calgary, Calgary, Alberta, T2N 4N1, Canada

    Christine M Friedenreich

  10. Department of Community Health Sciences, Faculty of Medicine, Faculty of Medicine, University of Calgary, Calgary, Alberta, T2N 4N1, Canada

    Christine M Friedenreich, Michael D Hill, David B Hogan & Eric E Smith

  11. Faculty of Kinesiology, University of Calgary, Calgary, Alberta, T2N 1N4, Canada

    Christine M Friedenreich & Marc J Poulin

  12. Department of Radiology, Faculty of Medicine, University of Calgary, Calgary, Alberta, T2N 4N1, Canada

    Michael D Hill & Eric E Smith

  13. Brenda Stafford Foundation Chair in Geriatric Medicine, Faculty of Medicine, University of Calgary, Calgary, Alberta, T2N 4N1, Canada

    David B Hogan

  14. Psychology Service, Alberta Health Services, Foothills Hospital, Calgary, Alberta, T2N 2T9, Canada

    R Stewart Longman

  15. University of Calgary, Calgary, Alberta, T2N 4N1, Canada

    Todd J Anderson & Marc J Poulin

  16. Department of Cardiac Science, Faculty of Medicine, University of Calgary, Calgary, Alberta, T2N 4N1, Canada

    Todd J Anderson

  17. Airway Inflammation Research Group, Faculty of Medicine, University of Calgary, Calgary, Alberta, T2N 4N1, Canada

    Richard Leigh

  18. Snyder Institute for Chronic Diseases, Faculty of Medicine, University of Calgary, Calgary, Alberta, T2N 4N1, Canada

    Richard Leigh

Authors
  1. Amanda V Tyndall
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Margie H Davenport
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ben J Wilson
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Grazyna M Burek
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Genevieve Arsenault-Lapierre
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Eryka Haley
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Gail A Eskes
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Christine M Friedenreich
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Michael D Hill
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. David B Hogan
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. R Stewart Longman
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Todd J Anderson
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Richard Leigh
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Eric E Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Marc J Poulin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marc J Poulin.

Additional information

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

GAE, CMF, MDH, DBH, RSL, TJA, RL, EES, MJP have made substantial contributions to conception and design of this study. AVT and MHD wrote the draft of the manuscript and all authors were involved in revising the manuscript critically for important intellectual content. BJW provided significant medical coverage for exercise testing. GMB and EH were involved in coordinating the study and recruitment. GAL contributed the social support questionnaire to the study. All authors have given final approval of the version to be published.

Authors’ original submitted files for images

Below are the links to the authors’ original submitted files for images.

Authors’ original file for figure 1

Rights and permissions

Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution License ( https://creativecommons.org/licenses/by/2.0 ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and Permissions

About this article

Cite this article

Tyndall, A.V., Davenport, M.H., Wilson, B.J. et al. The brain-in-motion study: effect of a 6-month aerobic exercise intervention on cerebrovascular regulation and cognitive function in older adults. BMC Geriatr 13, 21 (2013). https://doi.org/10.1186/1471-2318-13-21

Download citation

Keywords

  • Physical fitness
  • Cerebrovascular function
  • Cognition
  • Aging

BMC Geriatrics

ISSN: 1471-2318

Contact us